• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Dual-Wavelength Laser for Tattoo Removal?

A trial investigated the safety and efficacy of a dual-wavelength laser for tattoo removal.

A study published in Lasers in Surgery and Medicine investigated the safety and efficacy of a dual-wavelength laser for tattoo removal. 

A 1064/532-nm picosecond domain laser was used as treatment for tattoo removal in 30 enrolled patients from Vietnam with 52 tattoos at 6-to-8-week intervals. Both the safety and efficacy were evaluated at each treatment session and then 4 weeks after the final session. To be considered a “good” response to treatment, there needed to be 75% clearance of tattoo pigments. 

There was a reduction of tattoo appearance in all patients,l with 88.5% of tattoos achieving a “good” response to treatment and 36% achieving better than 75% clearance of pigment at the end of 6 sessions. Of the adverse events (AEs) reported, most did not persist and only one case of hypopigmentation was reported. 

The authors came to the conclusion that treatment with the 1064/532-nm picosecond domain laser is effective for tattoo removal and has a minimal risk of long-term AEs in patients that have a Fitzpatrick skin type III of IV. 

Reference:

1. Nguyen HT, Doan EVL, Tran TNA, Vu TTP, Phan HN, Sobanko JF. Safety and efficacy of tattoo removal using a dual-wavelength 1064/532-nm picosecond laser in patients with fitzpatrick skin type iii and iv. Lasers in Surgery and Medicine. n/a(n/a). Published October 7, 2020. Accessed June 23, 2021. doi:https://doi.org/10.1002/lsm.23333

Related Videos
© 2024 MJH Life Sciences

All rights reserved.